Physician profile
Jason E Nolan
NPI 1780650812
$7,185.09
in general payments reported to CMS, 2019-2025
44 companies · $833 in 2025
The $833 reported for 2025 was more than what 76% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,861 · 2020: $996 · 2021: $503 · 2022: $158 · 2023: $1,245 · 2024: $590 · 2025: $833.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,668.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,667.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $1,960.77 | 2019-2025 | Biobrace 23mm, Rts, Neospan |
| Smith+Nephew, INC. | $684.49 | 2019-2025 | Grafix Pl, Stravix, Collagenase Santyl |
| Convatec INC. | $604.76 | 2023-2025 | |
| Organogenesis INC. | $505.04 | 2019-2025 | Apligraf |
| Paratek Pharmaceuticals, INC. | $290.10 | 2021-2025 | Nuzyra |
| Epsfl, LLC | $283.80 | 2023 | |
| Kerecis Limited | $281.12 | 2019-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Amniox Medical, INC. | $265.40 | 2019 | |
| Horizon Therapeutics Plc | $236.93 | 2020-2023 | Krystexxa |
| Zimmer Biomet Holdings, INC. | $222.68 | 2019-2023 | Stratum Foot Plating System, Nextremity General Instrument, Tapestry |
| Cardiovascular Systems INC. | $180.14 | 2021-2022 | |
| Integra Lifesciences Corporation | $172.39 | 2021-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Stryker Corporation | $163.52 | 2023 | Easyfuse, Citrefix, Augment Injectable |
| Nevro Corp. | $162.16 | 2024 | Senza |
| Osiris Therapeutics INC. | $160.43 | 2019 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Nolan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.